Young Cancer Survivors May Require Lifelong Screenings

This article originally appeared here.
Share this content:
Young Cancer Survivors May Require Lifelong Screenings
Young Cancer Survivors May Require Lifelong Screenings

(HealthDay News) -- Teen and young adult cancer survivors are at increased risk for other cancers later in life, according to a study published online Oct. 6 in Cancer.

Researchers analyzed U.S. National Cancer Institute data for patients who survived cancers before age 40. Over 30 years, nearly 14 percent of the survivors were diagnosed with another, different type of cancer. On average, the second cancer occurred within 15 years. Compared to the general population, patients successfully treated for cancer between ages 15 and 39 were nearly 60 percent more likely to develop cancer. In contrast, patients successfully treated for cancer after age 40 were 10 percent more likely to develop another cancer.

The most common second cancers were breast, gastrointestinal and genital cancers, and melanoma. Over 30 years, those who received radiation therapy for their first cancer were more likely to have a second cancer than those who did not have radiation therapy -- about 17 percent compared to 12 percent. Of the 7,384 patients who developed second cancers, 1,195 also developed a third cancer.

"Cancer patients used to be told that after they had reached five years of remission, they no longer had special health care needs," senior author Robert Goldsby, M.D., a professor of pediatrics at the University of California, San Francisco, Benioff Children's Hospital, said in a university news release. "But our study demonstrates that adolescent and younger adult survivors require lifelong follow-up with regular medical screening."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs